Clinical trial
Gemtuzumab Ozogamicin Before Allogeneic Stem Cell Transplantation
NCT00460447 · University Hospital Carl Gustav Carus, Other · Unknown status
Key facts
| NCT number | NCT00460447 |
|---|---|
| Title | Gemtuzumab Ozogamicin Before Allogeneic Stem Cell Transplantation |
| Official title | Gentuzumab Ozogamicin Berfore Allogeneic Stem Cell Transplantation in Patients With Relapsed CD33+ Acute Myeloid Leukemia |
| Lead sponsor | University Hospital Carl Gustav Carus, Other |
| Status | Unknown status |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Acute Myeloid Leukemia, Allogeneic Transplantation |
| Intervention type | Drug |
| Interventions | Gemtuzumab Ozogamicin |
| Enrollment | 30 |
| Start date | Oct 1, 2004 |
| First posted | Apr 16, 2007 |
| Last update posted | Apr 16, 2007 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: